Scynexis (SCYX) Receivables - Net (2013 - 2023)
Scynexis' (SCYX) quarterly Receivables - Net came in at $2.2 million in Q3 2023, down 9.95% on a YoY basis from $2.5 million in Q3 2022, and down 4.26% quarter-over-quarter from $2.3 million in Q2 2023.
Analysis
Scynexis (SCYX) Receivables - Net (2013 - 2023) Analysis & Trends
Scynexis (SCYX) has reported Receivables - Net for 6 consecutive years, with $2.2 million the latest figure, recorded in Q3 2023.
- For the quarter ending Q3 2023, Receivables - Net fell 9.95% year-over-year to $2.2 million; the trailing twelve-month figure through Sep 2023 stood at $2.2 million (down 9.95% YoY), and the FY2022 full-year result was $2.1 million, up 144.02% from the prior year.
- Receivables - Net retreated to $2.2 million in Q3 2023 per SCYX's latest filing, from $2.3 million in the prior quarter.
- Across five years, Receivables - Net topped out at $2.5 million in Q3 2022 and bottomed at $29000.0 in Q3 2021.
- Historically, Receivables - Net has averaged $1.8 million across 3 years, with a median of $2.1 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net surged 8496.55% in 2022, then retreated 9.95% in 2023.
- Over 3 years, Receivables - Net stood at $861000.0 in 2021, then surged by 144.02% to $2.1 million in 2022, then rose by 6.85% to $2.2 million in 2023.
- According to Business Quant data, Receivables - Net over the past three periods registered $2.2 million, $2.3 million, and $2.1 million for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Sep 30, 2022 | 2.49 Mn |
| Jun 30, 2022 | 2.21 Mn |
| Mar 31, 2022 | 1.63 Mn |
| Dec 31, 2021 | 861,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Mar 31, 2015 | 681,000.00 |
| Dec 31, 2014 | 1.12 Mn |
| Sep 30, 2014 | 999,000.00 |
| Jun 30, 2014 | 965,000.00 |
| Mar 31, 2014 | 900,000.00 |
| Dec 31, 2013 | 719,000.00 |